Search

everythinglearnresearchcommunity

for

Search:↓

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

The man's rash, hair loss, and vision issues were due to syphilis, not CMV.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Skin tumors with CYLD cutaneous syndrome show more NF-κB activity and less organized collagen.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Supplemental testosterone may lower liver cancer risk in hepatitis C patients.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

lncRNA2919 slows down rabbit hair growth by stopping cell growth and causing cell death.

The Fas/FasL pathway may play a role in alopecia areata.

The assay effectively identifies compounds that affect immune cell activation.

COVID-19 vaccination may trigger recurrence of cutaneous T-cell lymphoma in some patients.

Enhancing Tregs can protect against alopecia areata.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Targeting specific T cells may help treat alopecia areata.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

circRNA-1926 helps goat stem cells turn into hair follicles by affecting miR-148a/b-3p and CDK19.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.